Zum Hauptinhalt springen

Buprenorphin

06. März 2020 | Buprenorphin

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study.

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study. Ahmadi J, Sarani EM, Jahromi MS. Ci Ji Yi Xue Za Zhi. 2019 Mar 14;32(1):58-64. doi: 10.4103/tcm…

01. März 2020 | Buprenorphin

Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.

Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial. Zamani N, Buckley NA, Hassanian-Moghaddam H. Crit Care. 2020 Feb 7;24(1):44. doi: 10.1186/s13054-020-2740-y. htt…

01. März 2020 | Buprenorphin

Sexual dysfunction in men on buprenorphine - naloxone-based substitution therapy.

Sexual dysfunction in men on buprenorphine - naloxone-based substitution therapy. Mattoo SK, Ghosh A, Subodh BN, Basu D, Satapathy A, Prasad S, Sharma MP. Indian J Psychiatry. 2020 Jan-Feb;62(1):66-72. doi: 10.4103/psychiatry.IndianJPsychiatry_195…

01. März 2020 | Buprenorphin

Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management.

Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management. Osborne V, Davies M, Roy D, Tescione F, Shakir SAW. BMJ Evid Based Med. 2020 Feb 24. pii: bmjebm-2019-111295. doi: 10.1136/bmjebm-2…

01. März 2020 | Buprenorphin

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworko…

29. Februar 2020 | Buprenorphin

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia.

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Larance, B., Degenhardt, L., Grebely, J., Nielsen, S., Bruno, R., Dietze, P., Lancaster, K., Larney, S., Santo, T…

08. Februar 2020 | Buprenorphin

Abuses of FDA Regulatory Procedures - The Case of Suboxone.

Abuses of FDA Regulatory Procedures - The Case of Suboxone. Haffajee RL, Frank RG. N Engl J Med. 2020 Feb 6;382(6):496-498. doi: 10.1056/NEJMp1906680. The manufacturer of brand-name buprenorphine products exploited various FDA regulatory pr…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten